Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
TOP STORIES — Diabetes News and Research
Depression + Diabetes = Increased Risk for Cardiovascular Outcomes
Nutritional Approach in Management of Diabetes or Prediabetes
Improving Glycemic Control in T1DM Can Decrease Risk of Fracture
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
#2 Predicting Diabetes Diagnoses Using Random Plasma Glucose
#3 Intermittent Fasting Beneficial for Weight Loss and Glycemic Control
Editor's Note
Our diabetes patients offer suffer from depression and we will blame it on the disease, when there is actually a clinical reason for their depression. This association of diabetes and depression is sometimes so great that patients don’t get the proper treatment for depression; over time this makes their diabetes worse, and now we are chasing the patient as they cascade into more and more problems.
This week our intern, Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy, has found one more effect of the diabetes, depression combination. Click here to learn what the combo has to do with cardiovascular disease.
Dave Joffe
Editor-in-chief
Newsflash: FDA Approves New Indication for Canagliflozin
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that FDA approved a new indication for canagliflozin (Invokana®) to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes and nephropathy with a certain amount of protein in the urine. INVOKANA® is now the only type 2 diabetes medicine indicated to both treat diabetic kidney disease and reduce the risk of hospitalization for heart failure in patients with T2D and DKD.
DISASTERS AVERTED — Near Miss Case Studies
My colleague and I were working with a client new to insulin. We each saw him separately. He was taking Lantus and Humalog by syringe at meals. He had been taught how to use the syringe by his physician’s office staff. He was claiming much different numbers than expected for his mealtime doses.
TOP STORIES — Diabetes News and Research
Patients who have diabetes should be screened for psychological risk factors.
How effective is medical nutrition therapy in improving diabetes and prediabetes outcomes?
Having diabetes increases patients’ risk for fracture six-fold in T1DM and three-fold in T2DM.
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.